EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions

J Victor Álvarez, Susana B Bravo iD, María Pilar Chantada-Vázquez iD, Carmen Pena, Cristóbal Colón iD, Shunji Tomatsu iD, Francisco J Otero-Espinar iD, María L Couce iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25063232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von J Victor Álvarez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Sciences, Pathology, Gynecology and Obstetrics, Pediatrics, Neonatology Service, Health Research Institute of Santiago de Comp…. Hauptthemen laut MEDLINE: Mucopolysaccharidosis IV, Cartilage Diseases, Bone Diseases, Chondroitinsulfatases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Investigación Sanitaria de Santiago, “Instituto de Salud Carlos III” (Plan Estatal de I+D+I 2023–2025 and European Development Regional Fund) of the Spanish Ministry of Economy and Competitiveness, MPS Lisosomales, National MPS Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome) is a rare autosomal recessive lysosomal storage disease (LSD) caused by deficiency of a hydrolase enzyme, N-acetylgalactosamine-6-sulfate sulfatase, and characterized clinically by mainly musculoskeletal manifestations. The mechanisms underlying bone involvement in humans are typically explored using invasive techniques such as bone biopsy, which complicates analysis in humans. We compared bone proteomes using DDA and SWATH-MS in wild-type and MPS IVA knockout mice (UNT) to obtain mechanistic information about the disease. Our findings reveal over 1000 dysregulated proteins in knockout mice, including those implicated in oxidative phosphorylation, oxidative stress (reactive oxygen species), DNA damage, and iron transport, and suggest that lactate dehydrogenase may constitute a useful prognostic and follow-up biomarker. Identifying biomarkers that reflect MPS IVA clinical course, severity, and progression have important implications for disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucopolysaccharidosis IVCartilage DiseasesBone DiseasesChondroitinsulfatasesHumansAnimalsMiceMice, Knockout

Stichwörter der Autor:innen

animal studiesbiomarkersmucopolysaccharidosis type IVmusculoskeletal manifestationsproteomic

Substanzen

Chondroitinsulfatases

Autor:innen und Institutionen

  • Department of Forensic Sciences, Pathology, Gynecology and Obstetrics, Pediatrics, Neonatology Service, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostel…
  • Health Research Institute of Santiago de Compostela (IDIS), CIBERER, MetabERN, 15706 Santiago de Compostela, Spain.
  • Proteomic Platform, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
  • Skeletal Dysplasia Lab Nemours Biomedical Research, Nemours Children's Health, 1600 Rockland Road, Wilmington, DE 19803, USA.
  • Paraquasil Platform, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
  • Department of Pharmacology, Pharmacy and Pharmaceutical Technology, School of Pharmacy, Campus Vida, University of Santiago de Compostela, 15872 Santiago de Compostela, Spain.

ORCID-Profile: Susana B Bravo, María Pilar Chantada-Vázquez, Cristóbal Colón, Shunji Tomatsu, Francisco J Otero-Espinar, María L Couce

Förderung

  • Instituto de Investigación Sanitaria de Santiago
  • “Instituto de Salud Carlos III” (Plan Estatal de I+D+I 2023–2025 and European Development Regional Fund) of the Spanish Ministry of Economy and Competitiveness
  • MPS Lisosomales, National MPS Society

Zitieren

APA

Álvarez, J. V., Bravo, S. B., Chantada-Vázquez, M. P., Pena, C., Colón, C., Tomatsu, S., Otero-Espinar, F. J., & Couce, M. L. (2024). Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063232

Vancouver

Álvarez JV, Bravo SB, Chantada-Vázquez MP, Pena C, Colón C, Tomatsu S, et al. Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063232

BibTeX
@article{lvarez2024,
  author = {Álvarez, J Victor and Bravo, Susana B and Chantada-Vázquez, María Pilar and Pena, Carmen and Colón, Cristóbal and Tomatsu, Shunji and Otero-Espinar, Francisco J and Couce, María L},
  title = {Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25063232}
}
Kostenlos starten →